Menu

Image of the Day: Pseudomonas Autophagy

Researchers identify antibacterial functions of cell death in Arabidopsis when the plant is infected with Pseudomonas.  

Mar 30, 2018
The Scientist Staff, The Scientist Staff

A plant cell (Arabidopsis) infected with Pseudomonas syringae, where the proteasome subunit PAG1 is labeled with a green fluorescent protein and ATG8a, an autophagy component, in purple. SUAYIB USTUN

Autophagy—the process by which cells break down and consume themselves—is one of the ways that eukaryotic organisms defend against microbial infections. In a study published this month in Plant Cell, researchers describe the mechanisms by which infection leads to autophagy. In Arabidopsis cells, they labelled PAG1, a subunit of the proteasome, and ATG8a, an autophagy-related protein, with fluorescent markers and observed their activity when the cells were infected with Pseudomonas syringae. The results showed “evidence for intimate crosstalk” between the two components of the plant’s infection response.  

S. Üstün et al., “Bacteria exploit autophagy for proteasome degradation and enhanced virulence in plants,” Plant Cell, doi:10.1105/tpc.17.00815, 2018.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.